The importance of collaboration among scientists – the treatment of severe hypercholesterolemia

• In: G20 - Short oral communications on Pharmaceutical Manufacturing and Drug Delivery Technologies on Wednesday, 3 September 2008, 9:00-11:49
• At: Basel (Switzerland) (2008)
• Type: Presentation
• By: NOVáKOVá, Lucie (Charles University, Faculty of Pharmacy, Hradec Králové, Czech Republic)
• Co-author(s): Šatínský, Dalibor (Charles University, Faculty of Pharmacy, Hradec Králové, Czech Republic)
  Bláha, Vladimír (Department of Metabolic Care and Gerontology, Teaching Hospital, Hradec Králové, Czech Republic)
  Solichová, Dagmar (Department of Metabolic Care and Gerontology, Teaching Hospital, Hradec Králové, Czech Republic)
  Solich, Petr (Charles University, Faculty of Pharmacy, Hradec Králové, Czech Republic)
  
• Abstract:

  Although the diet and successful development of hypolipidemics, especially inhibitors of 3-hydroxy-3-methlylglutaryl coenzyme A, enable relatively successful therapy of most patients, there is a minority of heterozygous patients with familiar hypercholesterolemia and all homozygous patients, where the therapy is not sufficient. Nowadays, the only

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login